Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 EUR | 0.00% | 0.00% | -40.00% |
2021 | Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment | MT |
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.89M 4.5M |
---|---|---|---|---|---|
Net income 2021 | -5M -4.6M | Net income 2022 | -5M -4.6M | EV / Sales 2021 | - |
Net cash position 2021 | 6.59M 6.07M | Net cash position 2022 | 3.7M 3.41M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.23
x | P/E ratio 2022 |
-0.87
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 47.54% |
1 month | -7.69% | ||
3 months | -40.00% | ||
6 months | -60.00% | ||
Current year | -40.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 0.006 | 0.00% | 0 |
24-05-15 | 0.006 | 0.00% | 0 |
24-05-14 | 0.006 | 0.00% | 0 |
24-05-13 | 0.006 | 0.00% | 0 |
24-05-10 | 0.006 | 0.00% | 0 |
Real-time Irish S.E., May 16, 2024 at 11:55 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-40.00% | 532K | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.44% | 22.28B | |
-11.90% | 22.41B | |
-4.73% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- OVXA Stock